Genovis AB
Records under this name other than the patents Genovis AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 7 of 7 · Back to Genovis AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,323,908 | Method of assessing glycosylation state or functional quality of an IgG containing sample Lapsed on the fee record Ended Dec 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2020 | From the USPTO record |
| US 8,557,289 | Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle Lapsed on the fee record Ended Oct 15, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 15, 2017 | From the USPTO record |
| US 6,833,355 | Use of protein H as cytostatic agent Lapsed on the fee record Ended Dec 21, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2016 | From the USPTO record |
| US 7,588,762 | Streptoccal Inhibitor of Complement-Mediated Lysis, Protein Sic Term ended Term ended Nov 15, 2016 · Medium confidence | Term ended | Term ended Nov 15, 2016 | Medium confidence |
| US 7,361,750 | Streptoccal Inhibitor of Complement-Mediated Lysis, Protein Sic Lapsed on the fee record Ended Apr 22, 2012 · Medium confidence | Lapsed on the fee record | Ended Apr 22, 2012 | Medium confidence |
| US 6,576,741 | Streptoccal inhibitor of complement-mediated lysis, protein SIC Lapsed on the fee record Ended Jun 10, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2011 | From the USPTO record |
| US 7,176,178 | Nuclear targeting by means of bacterial proteins Lapsed on the fee record Ended Feb 13, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2011 | From the USPTO record |